
### [Orphanet:90787](http://www.orpha.net/ORDO/Orphanet_90787)
**Label:** 46,XY disorder of sex development due to testicular steroidogenesis defect

**Subclasses:** [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [Orphanet:752](http://www.orpha.net/ORDO/Orphanet_752) (46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency), 

**Corr. equiv. classes:** [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [Orphanet:752](http://www.orpha.net/ORDO/Orphanet_752), [OMIM:264300](http://purl.obolibrary.org/obo/OMIM_264300), 

**Class expressions from DL-Learner:**

- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) 62.91%
- [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 56.26%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) 56.13%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 53.17%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 52.15%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 51.16%
- Thing 51.16%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 51.16%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0100607](http://purl.obolibrary.org/obo/HP_0100607) (Dysmenorrhea) 47.86%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0040171](http://purl.obolibrary.org/obo/HP_0040171) (Decreased serum testosterone level) 47.86%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 47.86%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0030349](http://purl.obolibrary.org/obo/HP_0030349) (Decreased circulating androgen level) 47.86%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0030347](http://purl.obolibrary.org/obo/HP_0030347) (Abnormal circulating androgen level) 47.86%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0030346](http://purl.obolibrary.org/obo/HP_0030346) (Abnormal circulating follicle-stimulating hormone level) 47.86%
- [HP:0012113](http://purl.obolibrary.org/obo/HP_0012113) (Abnormality of creatine metabolism) and [HP:0030345](http://purl.obolibrary.org/obo/HP_0030345) (Abnormal circulating luteinizing hormone level) 47.86%


